Angioimmunoblastic T‐cell lymphoma: Characterization of clonal T and B cells and a patient‐derived xenograft study of coexisting T‐ and B‐cell proliferation

Documenti analoghi

• Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient
  di: Dasom Lee, et al.
  Pubblicazione: (2024)
• B‐cell maturation antigen expression and clinical features of plasmablastic lymphoma
  di: Ning Dong, et al.
  Pubblicazione: (2024)
• Real‐world treatment of large B‐cell lymphoma with chimeric antigen receptor T‐cell therapy after loncastuximab tesirine
  di: Mehdi Hamadani, et al.
  Pubblicazione: (2024)
• Hepatic T cell lymphoma after chimeric antigen receptor T cell therapy for myeloma
  di: Joshua Mehr, et al.
  Pubblicazione: (2024)
• Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England
  di: Christopher P. Fox, et al.
  Pubblicazione: (2024)